GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cogstate Ltd (ASX:CGS) » Definitions » Total Liabilities

Cogstate (ASX:CGS) Total Liabilities : A$21.15 Mil (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Cogstate Total Liabilities?

Cogstate's Total Liabilities for the quarter that ended in Dec. 2023 was A$21.15 Mil.

Cogstate's quarterly Total Liabilities declined from Dec. 2022 (A$31.35 Mil) to Jun. 2023 (A$24.40 Mil) and declined from Jun. 2023 (A$24.40 Mil) to Dec. 2023 (A$21.15 Mil).

Cogstate's annual Total Liabilities declined from Jun. 2021 (A$38.72 Mil) to Jun. 2022 (A$36.32 Mil) and declined from Jun. 2022 (A$36.32 Mil) to Jun. 2023 (A$24.40 Mil).


Cogstate Total Liabilities Historical Data

The historical data trend for Cogstate's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cogstate Total Liabilities Chart

Cogstate Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.14 22.48 38.72 36.32 24.40

Cogstate Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.59 36.32 31.35 24.40 21.15

Cogstate Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cogstate's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=18.133+(0.04+0.00099999999999991
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+6.201+0.028)
=24.40

Total Liabilities=Total Assets (A: Jun. 2023 )-Total Equity (A: Jun. 2023 )
=80.56-56.157
=24.40

Cogstate's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=17.419+(0.003+3.433
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0.291+0)
=21.15

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=77.846-56.7
=21.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cogstate Total Liabilities Related Terms

Thank you for viewing the detailed overview of Cogstate's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Cogstate (ASX:CGS) Business Description

Traded in Other Exchanges
Address
161 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cogstate Ltd is a cognitive science company. The principal activity of the company is the sale of technology and services for the measurement of cognition, where services include scientific consultancy, project management, data management, statistical analysis, and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.

Cogstate (ASX:CGS) Headlines

No Headlines